145 related articles for article (PubMed ID: 24667606)
1. Targeted repression of AXIN2 and MYC gene expression using designer TALEs.
Rennoll SA; Scott SA; Yochum GS
Biochem Biophys Res Commun; 2014 Apr; 446(4):1120-5. PubMed ID: 24667606
[TBL] [Abstract][Full Text] [Related]
2. Nuclear AXIN2 represses MYC gene expression.
Rennoll SA; Konsavage WM; Yochum GS
Biochem Biophys Res Commun; 2014 Jan; 443(1):217-22. PubMed ID: 24299953
[TBL] [Abstract][Full Text] [Related]
3. A beta-catenin/TCF-coordinated chromatin loop at MYC integrates 5' and 3' Wnt responsive enhancers.
Yochum GS; Sherrick CM; Macpartlin M; Goodman RH
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):145-50. PubMed ID: 19966299
[TBL] [Abstract][Full Text] [Related]
4. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling.
Herbst A; Jurinovic V; Krebs S; Thieme SE; Blum H; Göke B; Kolligs FT
BMC Genomics; 2014 Jan; 15():74. PubMed ID: 24467841
[TBL] [Abstract][Full Text] [Related]
6. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.
Jho EH; Zhang T; Domon C; Joo CK; Freund JN; Costantini F
Mol Cell Biol; 2002 Feb; 22(4):1172-83. PubMed ID: 11809808
[TBL] [Abstract][Full Text] [Related]
7. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.
Leung JY; Kolligs FT; Wu R; Zhai Y; Kuick R; Hanash S; Cho KR; Fearon ER
J Biol Chem; 2002 Jun; 277(24):21657-65. PubMed ID: 11940574
[TBL] [Abstract][Full Text] [Related]
8. A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression.
Yochum GS; Cleland R; Goodman RH
Mol Cell Biol; 2008 Dec; 28(24):7368-79. PubMed ID: 18852287
[TBL] [Abstract][Full Text] [Related]
9. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
[TBL] [Abstract][Full Text] [Related]
10. Wnt/β-catenin signaling via Axin2 is required for myogenesis and, together with YAP/Taz and Tead1, active in IIa/IIx muscle fibers.
Huraskin D; Eiber N; Reichel M; Zidek LM; Kravic B; Bernkopf D; von Maltzahn J; Behrens J; Hashemolhosseini S
Development; 2016 Sep; 143(17):3128-42. PubMed ID: 27578179
[TBL] [Abstract][Full Text] [Related]
11. Wnt target enhancer regulation by a CDX/TCF transcription factor collective and a novel DNA motif.
Ramakrishnan AB; Chen L; Burby PE; Cadigan KM
Nucleic Acids Res; 2021 Sep; 49(15):8625-8641. PubMed ID: 34358319
[TBL] [Abstract][Full Text] [Related]
12. An aggregon in conductin/axin2 regulates Wnt/β-catenin signaling and holds potential for cancer therapy.
Bernkopf DB; Brückner M; Hadjihannas MV; Behrens J
Nat Commun; 2019 Sep; 10(1):4251. PubMed ID: 31534175
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma.
Wu C; Gupta N; Huang YH; Zhang HF; Alshareef A; Chow A; Lai R
BMC Cancer; 2018 Apr; 18(1):361. PubMed ID: 29609590
[TBL] [Abstract][Full Text] [Related]
14. Myc cooperates with β-catenin to drive gene expression in nephron progenitor cells.
Pan X; Karner CM; Carroll TJ
Development; 2017 Nov; 144(22):4173-4182. PubMed ID: 28993399
[TBL] [Abstract][Full Text] [Related]
15. AXIN2 gene silencing reduces apoptosis through regulating mitochondria-associated apoptosis signaling pathway and enhances proliferation of ESCs by modulating Wnt/β-catenin signaling pathway.
Fu F; Deng Q; Li R; Wang D; Yu QX; Yang X; Lei TY; Han J; Pan M; Zhen L; Li J; Li FT; Zhang YL; Li DZ; Liao C
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):418-427. PubMed ID: 31957856
[TBL] [Abstract][Full Text] [Related]
16. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
[TBL] [Abstract][Full Text] [Related]
17. Identification of zinc-finger BED domain-containing 3 (Zbed3) as a novel Axin-interacting protein that activates Wnt/beta-catenin signaling.
Chen T; Li M; Ding Y; Zhang LS; Xi Y; Pan WJ; Tao DL; Wang JY; Li L
J Biol Chem; 2009 Mar; 284(11):6683-9. PubMed ID: 19141611
[TBL] [Abstract][Full Text] [Related]
18. p15RS attenuates Wnt/{beta}-catenin signaling by disrupting {beta}-catenin·TCF4 Interaction.
Wu Y; Zhang Y; Zhang H; Yang X; Wang Y; Ren F; Liu H; Zhai Y; Jia B; Yu J; Chang Z
J Biol Chem; 2010 Nov; 285(45):34621-31. PubMed ID: 20739273
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY
Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
